Cargando…
Metformin inhibits cervical cancer cell proliferation via decreased AMPK O-GlcNAcylation
Metformin is a widely used drug for the treatment of type 2 diabetes. Antidiabetic drugs are also known to influence cancer progression, as high glucose levels affect both cancer and diabetes. Metformin induces cell cycle arrest in cancer cells, but the underlying mechanism remains unclear in cervic...
Autores principales: | Kim, Min Young, Kim, Yoon Sook, Kim, Minjun, Choi, Mee Young, Roh, Gu Seob, Lee, Dong Hoon, Kim, Hyun Joon, Kang, Sang Soo, Cho, Gyeong Jae, Shin, Jeong Kyu, Choi, Wan Sung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6711131/ https://www.ncbi.nlm.nih.gov/pubmed/31489252 http://dx.doi.org/10.1080/19768354.2019.1614092 |
Ejemplares similares
-
Quercetin induces cell death in cervical cancer by reducing O-GlcNAcylation of adenosine monophosphate-activated protein kinase
por: Ali, Akhtar, et al.
Publicado: (2018) -
O-GlcNAcylation of NF-κB Promotes Lung Metastasis of Cervical Cancer Cells via Upregulation of CXCR4 Expression
por: Ali, Akhtar, et al.
Publicado: (2017) -
Synergistic apoptosis by combination of metformin and an O-GlcNAcylation inhibitor in colon cancer cells
por: Lee, Da Eun, et al.
Publicado: (2023) -
Role and Function of O-GlcNAcylation in Cancer
por: Lee, Jii Bum, et al.
Publicado: (2021) -
O-GlcNAcylation in health and neurodegenerative diseases
por: Lee, Byeong Eun, et al.
Publicado: (2021)